T3Bioscience to Launch Novel Biostimulant Discovered via PROMISA Platform
T3Bioscience (T3), the US-based startup anchored in a powerful metabolite produced by Pseudomonas species, has announced its plans to launch a novel-mode-of-action biostimulant in 2027. Backed by a series of studies, its new product, RejuPrimeTM, has been shown to improve plant growth, performance, and yield under both normal and harsh abiotic stress conditions.
